
Quiz: What Agent Does ASCO Recommend for Frontline Stage IV Lung Cancer Treatment?
What single agent does the new ASCO guideline recommend for first-line treatment of patients with stage IV non-small-cell lung cancer without positive markers but with high PD-L1 expression? Is there an age limit for use of SBRT for early-stage lung cancer? Test your knowledge in our latest quiz.
Is there an age limit for use of stereotactic body radiation therapy (SBRT) for early-stage lung cancer? What single agent does the new American Society of Clinical Oncology (ASCO) guideline recommend for first-line treatment of patients with stage IV non-small-cell lung cancer (NSCLC) without positive markers but with high programmed death ligand 1 (PD-L1) expression? Test your knowledge in our latest quiz.
Question 1
Answer
D.Pembrolizumab
According to the ASCO
Question 2
Answer
A. 3%
According to the
Question 3
Answer
D. Recent smokers
Recent smokers had a hazard ratio (HR) of 0.38 (P P P = .0208 and HR, 1.62; P = .236) and never smokers (HR, 1.025; P = .971 and HR, 1.33; P = .638), respectively. “Sequencing data revealed that mutational burden was not associated with veliparib benefit,” the
Question 4
Answer
A. Median overall survival was similar between both arms
The
Question 5
Answer
A. Higher rate of grade 3 or higher pneumonitis
The grade 3 or higher pneumonitis rate was 1.3% vs 1.6% vs 1.5% (P = 1.0) in patients aged
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.